Gaining precision on the Alzheimer’s Disease Assessment Scale-cognitive: A comparison of item response theory-based scores and total scores

[1]  F. Samejima.  Estimation of latent ability using a response pattern of graded scores , 1969 .

[2]  L. Tucker,et al.  A reliability coefficient for maximum likelihood factor analysis , 1973 .

[3]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[4]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[5]  F. Baker.  The basics of item response theory , 1985 .

[6]  P. Bentler,et al.  Comparative fit indexes in structural models. , 1990, Psychological bulletin.

[7]  J. Mckillip,et al.  Fundamentals of item response theory , 1993 .

[8]  K. Davis.  Cholinesterase Inhibitors in Alzheimer's Disease , 1994, Neuropsychopharmacology.

[9]  Rex B. Kline,et al.  Principles and Practice of Structural Equation Modeling , 1998 .

[10]  Y. Agid,et al.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialCommentary: Another piece of the Alzheimer's jigsaw , 1999 .

[11]  P. Bentler,et al.  Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives , 1999 .

[12]  P Dal-Bianco,et al.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. , 1999, BMJ.

[13]  G. Wilcock,et al.  Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial , 2000, BMJ : British Medical Journal.

[14]  D. Thissen,et al.  Item response theory for items scored in more than two categories , 2000 .

[15]  D. Wilkinson,et al.  Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease , 2001, International journal of geriatric psychiatry.

[16]  David Thissen,et al.  Item Response Theory for Items Scored in Two Categories , 2001 .

[17]  W. Chan,et al.  Changing Patient Characteristics and Survival Experience in an Alzheimer’s Center Patient Cohort , 2005, Dementia and Geriatric Cognitive Disorders.

[18]  J. Birks,et al.  Cholinesterase inhibitors for Alzheimer's disease. , 2006 .

[19]  S. Fay,et al.  The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial , 2007, BMC neurology.

[20]  P. Raina,et al.  Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline , 2008, Annals of Internal Medicine.

[21]  V. Hachinski.  Shifts in thinking about dementia. , 2008, JAMA.

[22]  N. Fox,et al.  Assessment of neurological and behavioural function: the NIH Toolbox , 2010, The Lancet Neurology.

[23]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.